|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD
121.11 million
|
|
CAGR
(2023-2028)
|
4.30%
|
|
Fastest
Growing Segment
|
Oral
|
|
Largest
Market
|
North
America
|
Market Overview
Global Animal Sedative Market has valued at USD 121.11 million in 2022 and is anticipated to project impressive growth in the forecast
period with a CAGR of 4.30% through 2028. The animal sedative market saw a
notable disruption during the initial phase of the COVID-19 pandemic. This was
primarily due to the extensive implementation of containment measures like
lockdowns and social distancing by governments worldwide, which significantly
reduced the operations of veterinary hospitals and pharmacies. For instance, a
study conducted by Faunalytics in December 2022 revealed that in order to
prevent disease transmission during the pandemic, approximately 70% of clinics
in the United States and Canada temporarily suspended public access, leading to
situations where animals had to attend appointments without their owners or
guardians.
Key Market Drivers
Increasing Pet Ownership
Pet ownership has become a global phenomenon, with
millions of households worldwide welcoming furry, feathered, or scaly
companions into their lives. This surge in pet ownership is not just about
companionship; it's also driving growth in various industries, including
veterinary care and pharmaceuticals.
As more people open their homes to pets, there is a
growing emphasis on pet healthcare. Pet owners are increasingly recognizing the
importance of regular veterinary check-ups, vaccinations, and surgical
procedures when needed. For these medical interventions, sedation is often
required to ensure the safety and comfort of the animals.
The rise in pet ownership has translated into a
higher number of visits to veterinary clinics. Whether for routine check-ups,
vaccinations, or more complex procedures, these visits require sedation in many
cases. Consequently, the increased footfall in veterinary clinics is driving up
the demand for animal sedatives.
The pet industry is evolving, with a growing number
of specialty veterinary services emerging. These specialties include
dermatology, cardiology, dentistry, and even pet rehabilitation. Many of these
specialized treatments involve procedures that require sedation. The expanding
array of veterinary specialties further drives the demand for a variety of
sedatives tailored to specific medical needs.
With the rise of pet ownership, there is also a
heightened awareness of pet welfare. Pet owners are more concerned than ever
about the well-being and comfort of their animals. This has led to a demand for
sedatives that not only ensure the safety of the pet during procedures but also
minimize stress and discomfort, aligning with the principles of animal welfare.
As pets live longer, there is an increasing need
for geriatric care. Older pets often require more frequent medical attention,
including diagnostic procedures and surgeries. Sedation plays a vital role in
ensuring that these older animals can undergo necessary medical interventions
without undue stress or discomfort.
A growing number of pet owners are seeking
solutions for behavioral and anxiety-related issues in their pets. Sedation can
be a valuable tool in helping pets cope with anxiety or aggression problems,
facilitating behavioral therapy sessions. The demand for sedatives to manage
these issues is driving growth in the animal sedative market.
In emerging economies, a rising middle class is
contributing to an increase in pet ownership. As these populations grow, so
does the demand for pet-related services, including veterinary care. This
demographic shift is fostering a global increase in the pet healthcare market,
benefiting the animal sedative sector.
Advancements in Veterinary Medicine
The global animal sedative market is witnessing a
remarkable surge in demand, thanks to continuous advancements in veterinary
medicine. As the field of veterinary medicine continues to evolve,
incorporating cutting-edge techniques and technologies, it is also propelling
the growth of the animal sedative market.
Advancements in veterinary medicine have led to an
increased adoption of minimally invasive surgical procedures. These procedures
often require the use of sedatives to ensure that animals remain calm and
motionless during surgery. With the rising preference for less invasive
approaches, the demand for high-quality animal sedatives has surged.
Veterinarians are increasingly embracing precision
medicine, tailoring treatments to individual animals based on their unique
needs. This approach requires precise control over anesthesia and sedation to
accommodate variations in animal size, breed, and health condition. Advanced
sedatives offer veterinarians the flexibility to provide personalized care,
thereby driving the growth of the animal sedative market.
Innovations in drug delivery systems have allowed
for more precise and controlled administration of sedatives. This not only
ensures that the animal receives the right dose but also enables quicker onset
and recovery. Veterinarians are now able to provide more efficient care,
enhancing the overall experience for both pets and their owners.
Modern veterinary medicine places a strong emphasis
on pain management. Animal sedatives play a critical role in this aspect, as
they help alleviate pain and reduce stress during procedures. The development
of sedatives that are effective in managing pain while maintaining safety has
become a key focus, driving demand in the animal sedative market.
Veterinary medicine is diversifying, with
specialized services such as oncology, cardiology, neurology, and dentistry
becoming more prevalent. Many of these specialized fields require unique
sedation protocols tailored to the specific needs of patients. As specialized
veterinary services expand, so does the demand for a variety of sedatives.
Advancements in anesthesia monitoring technology
have greatly improved the safety and effectiveness of sedation in veterinary
medicine. These technologies allow veterinarians to closely monitor vital
signs, ensuring the well-being of the animal throughout the procedure. As these
monitoring systems become more sophisticated and accessible, they drive the use
of sedatives in veterinary practices.
Increasing Awareness of Animal Welfare
In recent years, there has been a significant shift
in societal attitudes towards the treatment of animals. As the awareness of
animal welfare concerns continues to grow, it is not only reshaping the way we
care for our animal companions but also propelling the growth of the global
animal sedative market.
Awareness of animal welfare issues has led to a
greater emphasis on humane treatment across various sectors, including
veterinary medicine. Pet owners and veterinarians are increasingly focused on
ensuring that medical procedures, surgeries, and diagnostic tests are conducted
with the utmost consideration for the well-being and comfort of the animal.
This often involves the use of sedatives to minimize stress and pain during
these procedures.
Stress and anxiety can have detrimental effects on
an animal's health and recovery process. The awareness of these negative
impacts has led to a heightened demand for sedatives that effectively reduce
stress and anxiety in animals. As a result, pharmaceutical companies are
developing and marketing sedatives designed to provide a calm and stress-free
experience for animals, ultimately boosting the animal sedative market.
With increased awareness of animal welfare, there
is a growing understanding of the responsibilities that come with pet
ownership. Pet owners are more inclined to ensure that their animals receive
proper medical care and attention. This includes sedation when necessary,
fostering a culture of responsible pet ownership that contributes to the growth
of the animal sedative market.
Veterinary organizations and governmental agencies
are enacting guidelines and regulations that prioritize the welfare of animals.
These regulations often require veterinarians to use sedatives when conducting
certain procedures, especially those that may cause distress or pain.
Compliance with these regulations drives the demand for sedatives, encouraging
market growth.
Animal welfare advocates and veterinarians are
increasingly focused on pain management for animals. Sedatives are essential in
providing pain relief and reducing suffering during surgeries and other medical
procedures. The awareness of the importance of pain management has led to the
development of specialized sedatives for this purpose, further fueling market
growth.
Animal welfare organizations, including animal
shelters and rescue groups, play a vital role in promoting animal welfare.
These organizations often require sedatives to manage and treat animals that
have experienced trauma or neglect. As the awareness of their efforts grows, so
does the demand for sedatives to assist in their work.
Educational campaigns and initiatives focused on
animal welfare have reached a broad audience, from schoolchildren to adults.
These efforts not only foster empathy and compassion but also educate
individuals about the importance of veterinary care and the role of sedation in
ensuring the well-being of animals. This education contributes to the long-term
growth of the animal sedative market.
Growth in Livestock Production
The livestock industry is a critical component of
global agriculture, providing essential resources like meat, milk, and eggs to
billions of people worldwide. As livestock production continues to expand to
meet the growing demand for animal-based products, it's also contributing to
the growth of the global animal sedative market.
Livestock, such as cattle, sheep, and pigs, require
various veterinary procedures throughout their lives, including vaccinations,
surgeries, and reproductive interventions. Many of these procedures necessitate
sedation to ensure the safety of both the animals and the veterinarians. With
the global demand for livestock products on the rise, so is the need for animal
sedatives.
Stress can have adverse effects on the health and
productivity of livestock. High-stress levels can lead to weight loss, reduced
fertility, and even disease susceptibility. Animal sedatives help reduce stress
during transportation, handling, and medical procedures, contributing to the
overall well-being of the animals and the quality of their products.
The welfare of animals in livestock production is
an increasing concern. Consumers and regulatory bodies are pushing for better
living conditions and humane treatment of livestock. Sedatives are used to
manage and alleviate pain and discomfort in animals undergoing surgical or
medical interventions, aligning with improved animal welfare standards.
Efforts to maximize livestock productivity have led
to the development of advanced breeding and genetics programs. These programs
often require reproductive procedures and artificial insemination, which may
involve sedation. Sedatives ensure that these procedures are conducted
efficiently and safely, contributing to increased livestock productivity.
The growth of the livestock market extends to
specialty livestock, such as exotic or high-value animals. These animals may
require specialized medical care and sedation for various reasons, including
routine health checks, diagnostics, or assisted reproduction. As the demand for
specialty livestock rises, so does the need for sedatives.
The expansion of livestock production has spurred
the growth of veterinary services specializing in farm animal care. These
veterinary practices often provide comprehensive medical care for large numbers
of animals, including sedation when necessary. The increased availability of
veterinary services for livestock boosts the demand for sedatives.
Download Free Sample Report
Key Market Challenges
Ethical Concerns
The ethical concerns associated with animal testing
have become a significant issue for the industry. Balancing the need for safety
and efficacy testing with the desire to minimize animal suffering is an ongoing
challenge. Companies are increasingly exploring alternative testing methods and
striving to reduce their reliance on animal testing.
Resistance and Tolerance
Just as in human medicine, animals can develop
resistance or tolerance to sedatives over time. This poses challenges for
veterinarians who need to adapt treatment protocols or seek alternative
sedatives. Manufacturers must continually innovate to develop new sedatives or
formulations to combat resistance.
Supply Chain Disruptions
Global events, such as the COVID-19 pandemic, have
highlighted vulnerabilities in supply chains. Disruptions in the supply of raw
materials or finished products can impact the availability of animal sedatives.
Manufacturers must diversify supply sources and implement robust contingency
plans to mitigate such disruptions.
Key Market Trends
Advancements in Sedative Formulations
Innovations in pharmaceutical research are leading
to the development of safer, more effective, and faster-acting sedatives. These
advanced formulations are designed to enhance the overall experience for both animals
and veterinarians, reducing procedure times and post-sedation recovery.
Customized Sedation Protocols
Personalized medicine is gaining traction in
veterinary care, leading to customized sedation protocols. Veterinarians tailor
sedation to individual animal needs, considering factors like age, breed, and
health condition. This trend is expected to grow as precision medicine becomes
more prevalent.
Alternative Sedation Methods
With concerns over the use of traditional
sedatives, there's a growing interest in alternative sedation methods. This
includes the use of natural or non-pharmaceutical sedatives, such as herbal
remedies or behavioral modification techniques. These alternatives align with
the desire for more holistic and natural approaches to animal care.
Segmental Insights
Type Insights
Based on the category of Type, Acepromazine is
poised to dominate the Global Animal Sedative Market in 2022 and maintain its
stronghold throughout the forecast years for several compelling reasons.
Firstly, Acepromazine boasts a long-standing reputation for its efficacy and
safety in sedating a wide range of animals, from small pets to large livestock,
making it a trusted choice among veterinarians and animal caregivers worldwide.
Additionally, the drug's consistent quality and reliable results have earned it
the trust of the global veterinary community. Furthermore, Acepromazine's
cost-effectiveness compared to alternative sedatives positions it as an
attractive option, particularly in regions where cost considerations play a
significant role in decision-making. As research and development efforts
continue to refine its formulation and delivery methods, Acepromazine is
well-positioned to meet evolving market demands, ensuring its dominance in the
Global Animal Sedative Market for years to come.
Route of Administration Insights
The Parenteral route of administration is poised to
dominate the Global Animal Sedative Market, while oral alternatives are
expected to experience substantial growth during the forecast years. Parenteral
sedatives, delivered through injections or intravenous means, have long been
favored for their immediate and precise effects, making them the preferred
choice for critical or emergency situations in veterinary practice. However,
oral sedatives are anticipated to grow in popularity due to their ease of
administration, reduced stress on animals, and increased convenience for
caregivers, particularly for routine procedures and home care. This anticipated
growth in the oral segment reflects a shift towards more humane and accessible
sedation options for animals, while Parenteral sedatives will continue to hold
a strong position in scenarios where rapid sedation is imperative. As the
market evolves to accommodate diverse needs, both Parenteral and oral segments
are expected to coexist and collectively drive the expansion of the Global
Animal Sedative Market.
Download Free Sample Report
Regional Insights
North America is poised to maintain a substantial
market share in the upcoming forecast period, driven by factors such as the
growing adoption of pets and an increase in per capita spending on animal
healthcare. Furthermore, the rising incidence of various animal illnesses and
injuries is a key catalyst for market expansion. According to the 2020-2021
National Pet Owners Survey conducted by the American Pet Products Association
(APPA), there were approximately 69 million dogs and 45.3 million cats in U.S.
households. This surge in pet ownership has led North American citizens to
become increasingly conscientious about their animals' well-being. Notably, the
2022 State of the Industry Report by the North American Pet Health Insurance
Association (NAPHIA) revealed that the total premium volume for pet insurance
in the U.S. reached nearly USD 2.6 billion. The number of insured pets in the
U.S. grew by 28 percent since 2020, totaling 3.9 million at the end of 2021.
With a heightened focus on animal health and expenditure, the market is poised
for significant future growth. Furthermore, the market is being propelled by
the surge in partnerships, agreements, mergers, and acquisitions among industry
players. For example, in November 2022, Noe Animal Hospital expanded its
services to offer a comprehensive range of veterinary care in San Francisco and
surrounding areas, including wellness check-ups, vaccinations, dental care, and
more.
Recent Developments
- In November 2022, SeQuent Scientific Limited
(SeQuent), a prominent Indian company specializing in animal health products,
particularly veterinary formulations and APIs, entered into a binding agreement
to purchase the entire ownership stake, equivalent to 100%, in Tineta Pharma
Private Limited (Tineta), an Indian-based company.
- In March 2022, the U.S. Food and Drug
Administration granted approval for Zenalpha (medetomidine and vatinoxan
hydrochlorides injection) as a sedative and analgesic medication designed to
maintain dogs in a sedated and comfortable state during medical examinations or
specific medical procedures.
Key Market Players
- Zoetis Inc
- Boehringer
Ingelheim International GmbH
- Merck
& Co., Inc.
- Elanco
Animal Health Inc
- Virbac SA
- Dechra
Pharmaceuticals PLC
- Orion
Corporation
- Vetoquinol
SA
|
By Type
|
By Route of Administration
|
By Region
|
- Acepromazine
- Butorphanol
- Detomidine
- Romifidine
- Xylazine
|
|
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
|
Report Scope:
In this report, the Global Animal Sedative Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- Animal Sedative Market, By Type:
o Acepromazine
o Butorphanol
o Detomidine
o Romifidine
o Xylazine
- Animal Sedative Market, By Route of Administration:
o Oral
o Parenteral
- Animal Sedative Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ Germany
§ United Kingdom
§ France
§ Italy
§ Spain
o Asia-Pacific
§ China
§ Japan
§ India
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Animal
Sedative Market.
Available Customizations:
Global Animal Sedative market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Animal Sedative Market is an upcoming report
to be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]